Erythrocin and Norvasc drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Erythrocin (erythromycin lactobionate) and Norvasc (amlodipine besylate). Common drug interactions include chest pain among females and pneumonia among males.
The phase IV clinical study analyzes what interactions people have when they take Erythrocin and Norvasc. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.
What is Erythrocin?
Erythrocin has active ingredients of erythromycin lactobionate. It is often used in tooth abscess. eHealthMe is studying from 1,200 Erythrocin users. Check the latest studies of Erythrocin.
What is Norvasc?
Norvasc has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 136,738 Norvasc users. Check the latest studies of Norvasc.
46 people who take Erythrocin and Norvasc together, and have interactions are studied.

What are the common drug interactions of Erythrocin and Norvasc, by gender? *:
female:
- Chest pain
- Fall
- Loss of consciousness
- Muscle weakness (a lack of muscle strength)
- Altered state of consciousness (altered state of mind)
- Anaemia neonatal
- Asthenia (weakness)
- Ataxia (loss of full control of bodily movements)
- Cerebral cyst (fluid filled tumour of brain)
- Cerebral infarction (less blood supply to brain resulting tissue damage)
male:
- Pneumonia
- Oxygen saturation decreased
- Diabetes mellitus inadequate control
- Emotional distress
- Hyperhidrosis (abnormally increased sweating)
- Hypokalaemia (low potassium)
- Interstitial lung disease
- Lung abscess (pus in lungs)
- Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
- Nausea (feeling of having an urge to vomit)
What are the common drug interactions of Erythrocin and Norvasc, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Chest pain
- Loss of consciousness
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Renal tubular necrosis (death of kidney tubules)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
50-59:
- Muscle weakness (a lack of muscle strength)
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Difficulty in walking
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Lumbar spinal stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone)
- Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
- Oedema (fluid collection in tissue)
- Chronic kidney disease
- Renal injury (kidney injury)
60+:
- Pneumonia
- Oxygen saturation decreased
- Diabetes mellitus inadequate control
- Emotional distress
- Hyperhidrosis (abnormally increased sweating)
- Hypokalaemia (low potassium)
- Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
- Nausea (feeling of having an urge to vomit)
- Occult blood positive
- Pain
What are the existing conditions these people have? *
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 23.91%
- Depression: 5 people, 10.87%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 8.70%
- Pain: 4 people, 8.70%
- Nausea (feeling of having an urge to vomit): 4 people, 8.70%
- Infection: 4 people, 8.70%
- Hypersensitivity: 4 people, 8.70%
- High Blood Cholesterol: 4 people, 8.70%
- Diabetes: 4 people, 8.70%
- Chronic Kidney Disease: 4 people, 8.70%
* Approximation only. Some reports may have incomplete information.
Do you take Erythrocin and Norvasc?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Erythrocin (1,200 reports)
- Norvasc (136,738 reports)
Browse all drug interactions of Erythrocin and Norvasc:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Erythrocin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Norvasc:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Erythrocin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Norvasc and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on erythromycin lactobionate and amlodipine besylate (the active ingredients of Erythrocin and Norvasc, respectively), and Erythrocin and Norvasc (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Piperacillin and Polaramine - 2 seconds ago
- Could Nuvaring cause Wound? - 7 seconds ago
- Hypopituitarism and Anxiety Aggravated - 10 seconds ago
- Drug interactions of Pulmicort Respules and Prednisolone - 25 seconds ago
- Could Cyclosporine cause Hepatotoxicity? - 36 seconds ago
- Could Folic Acid cause Rheumatoid Nodule? - 50 seconds ago
- Drug interactions of Allopurinol and Chondroitin Sulfate - 50 seconds ago
- Could Coumadin cause Hair Growth Abnormal? - 54 seconds ago
- Drug interactions of Robaxin-750 and Lantus - a minute ago
- Could Multihance cause Eyelid Oedema? - a minute ago